Park Ha Biological Technology Co., Ltd.
PHH
$0.4785
$0.00050.11%
NASDAQ
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -18.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -18.95% | |||
| Cost of Revenue | 0.00% | -39.71% | |||
| Gross Profit | 0.00% | -17.53% | |||
| SG&A Expenses | 0.00% | 2,823.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 2,432.00% | |||
| Operating Income | 0.00% | -2,910.89% | |||
| Income Before Tax | 0.00% | -2,907.34% | |||
| Income Tax Expenses | 0.00% | -33.80% | |||
| Earnings from Continuing Operations | 0.00% | -4,717.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -4,717.32% | |||
| EBIT | 0.00% | -2,910.89% | |||
| EBITDA | 0.00% | -2,863.75% | |||
| EPS Basic | 0.00% | -4,389.53% | |||
| Normalized Basic EPS | 0.00% | -2,696.59% | |||
| EPS Diluted | 0.00% | -4,389.53% | |||
| Normalized Diluted EPS | 0.00% | -2,696.59% | |||
| Average Basic Shares Outstanding | 0.00% | 7.55% | |||
| Average Diluted Shares Outstanding | 0.00% | 7.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||